6 completed, 3 unknown, 2 withdrawn, 1 not yet recruiting. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 6, Unknown 3, Withdrawn 2, Not yet recruiting 1, Terminated 1 |
Follow Vascular Disease: new trials by email Literature Review of Vascular Disease trials Research Report on Vascular Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes Montelukast, Placebo - Diabetes, Kidney Disease | Phase 4 | Not yet recruiting | University of Colorado, Denver | 110 | 2026-09-01 | 2026-07-06 |
| Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging Dexamethasone infusion, Drug coated balloon, Plain balloon angioplasty - Peripheral Artery Disease, Vascular Disease | Phase 4 | Completed | University of California, San Francisco | 33 | 2016-02-10 | 2025-07-17 |
| Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients Ticagrelor, clopidogrel - Peripheral Artery Disease, Vascular Disease | Phase 4 | Withdrawn | AstraZeneca | 2014-12-01 | 2014-10-15 | |
| Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy clopidogrel, Ticagrelor or prasugrel - Coronary Artery Disease, Myocardial Infarction | Phase 4 | Unknown | Imam Abdulrahman Bin Faisal University | 1500 | 2013-03-01 | 2016-01-22 |
| Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy Ramipril, Clopidogrel - Diabetes Type 2, Diabetic Nephropathy | Phase 4 | Unknown | AHEPA University Hospital | 60 | 2012-07-01 | 2012-12-06 |
| Graz Study on the Risk of Atrial Fibrillation Medtronic Reveal XT implantable loop recorder - Atrial Fibrillation, Hypertension | Phase 4 | Unknown | Medical University of Graz | 82 | 2011-11-01 | 2015-12-22 |
| Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol Esmolol, Metoprolol - Vascular Disease, Hypertension | Phase 4 | Terminated | University Health Network, Toronto | 20 | 2011-04-01 | 2015-04-21 |
| Clinical Trial of a Silver Eluting Dressing System Surgical dressing - Vascular Disease, Surgery | Phase 4 | Completed | Brigham and Women's Hospital | 500 | 2010-10-01 | 2016-01-12 |
| XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT) XIENCE V EECSS, CYPHER SELECT PLUS SECSS - Coronary Occlusion, Thrombosis (Stent Thrombosis) | Phase 4 | Completed | Abbott Medical Devices | 546 | 2010-08-01 | 2016-08-24 |
| XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort placebo + aspirin, clopidogrel + aspirin OR prasugrel + aspirin, XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS) - Chronic Total Occlusion of Coronary Artery, Vascular Disease | Phase 4 | Completed | Abbott Medical Devices | 870 | 2009-08-01 | 2023-11-14 |
| XIENCE V: SPIRIT WOMEN Sub-study XIENCE V®/ XIENCE PRIME™, CYPHER SELECT - Coronary Artery Stenosis, Coronary Arteriosclerosis | Phase 4 | Completed | Abbott Medical Devices | 455 | 2008-09-01 | 2012-08-07 |
| XIENCE V: SPIRIT WOMEN XIENCE V®/ XIENCE PRIME™ - Coronary Artery Stenosis, Coronary Arteriosclerosis | Phase 4 | Completed | Abbott Medical Devices | 1600 | 2007-07-01 | 2015-05-13 |
| Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study Home blood pressure measurement, Office blood pressure measurement - Cardiovascular Disease, Vascular Disease | Phase 4 | Withdrawn | Kyoto University, Graduate School of Medicine | 2006-10-01 | 2015-12-29 |
Vascular Diseases (13) · Coronary Artery Disease (5) · Coronary Restenosis (4) · Coronary Stenosis (4) · Myocardial Ischemia (4) · Diabetes Mellitus (3) · Hypertension (3) · Angina Pectoris (2) · Cardiovascular Diseases (2) · Coronary Disease (2) · Heart Diseases (2) · Intermittent Claudication (2) · Peripheral Arterial Disease (2) · Thrombosis (2) · Atherosclerosis (1)
Cardiovascular Diseases (11) · Arterial Occlusive Diseases (7) · Arteriosclerosis (7) · Heart Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (4) · Coronary Disease (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Pathologic Processes (3) · Embolism and Thrombosis (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2)
Clopidogrel (4) · Prasugrel Hydrochloride (2) · Ticagrelor (2) · Aspirin (1) · Metoprolol (1) · Ramipril (1) · esmolol (1) · montelukast (1)
Abbott Medical Devices (4) · AHEPA University Hospital (1) · AstraZeneca (1) · Brigham and Women's Hospital (1) · Imam Abdulrahman Bin Faisal University (1) · Kyoto University, Graduate School of Medicine (1) · Medical University of Graz (1) · University Health Network, Toronto (1) · University of California, San Francisco (1) · University of Colorado, Denver (1)
United States (4) · Austria (3) · Argentina (2) · Belgium (2) · Brazil (2) · China (2) · Denmark (2) · France (2) · Germany (2) · Greece (2) · Hungary (2) · Italy (2) · Latvia (2) · Netherlands (2) · Norway (2)
Marie-Claude Morice (2) · Stephan Windecker (2) · Abdullah M Al-Rubaish, MD (1) · Amein K Al-Ali, PhD (1) · C Keith Ozaki, MD (1) · David Saloner, PhD (1) · Fotios S Iliadis, Lecturer of Internal Medicine (1) · Gabriel Vorobiof, MD (1) · Gao Runlin, MD, FACC (1) · Hiroaki Matsubara, MD, PhD (1) · James Hermiller, MD (1) · Jessica Kendrick, MD MPH (1) · Matthew Budoff, MD (1) · Mitch Krucoff, MD (1) · Scott Beattie, MD, FRCP (1)
PMID 25175629, PMID 25940520, PMID 28796809, PMID 32493215, PMID 35224730, PMID 41159585
R01HL128816 (1)